Propedix is a biopharma and consumer health company focused on developing science-backed treatments for fungal conditions, particularly Athlete’s Foot. Their upcoming product, set to launch in early 2025, aims to provide effective relief for patients suffering from these common infections.
Funding
$800K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Athlete's Foot and other fungal conditions are common infections that cause discomfort and can be persistent, impacting the quality of life for many individuals. Current treatments may not always provide effective or lasting relief.
Solution
Propedix is developing science-backed treatments for fungal conditions, with an initial focus on Athlete's Foot. Their upcoming product, slated for launch in early 2025, is designed to provide effective relief for patients suffering from these infections. The company aims to innovate in the healthcare sector by providing solutions grounded in scientific research.
Target Audience
The primary target audience is individuals affected by Athlete's Foot and other fungal conditions seeking effective and science-backed treatment options.
Features
- Development of novel treatments for Athlete's Foot.
- Science-backed formulations for efficacy.
- Focus on the biopharmaceutical and consumer health sectors.